-
Hainan Province Unveils Measures to Support Innovative Drugs and Medical Devices Development
•
Hainan provincial bureaus, including the Healthcare Security Administration (HSA), Healthcare Commission, and Medical Products Administration, along with five other bureaus, have jointly issued a set of Measures to “Support the Development of Innovative Drugs and Medical Devices in Hainan Province.” The initiative aims to ensure seamless integration between the market…
-
China’s NHSA Aims to Balance Drug Prices with New Monitoring System by March 2024
•
The National Healthcare Security Administration (NHSA) has issued a notification aimed at fostering inter-provincial price fairness, integrity, transparency, and balance for drugs sharing the same generic names and manufacturers. The initiative involves a comprehensive review and inspection of drugs based on four criteria: generic name, manufacturer, dosage form, and specification.…
-
Guangxi HSA Expands Coverage for Assisted Reproductive Medical Services Under BMI
•
The Healthcare Security Administration (HSA) bureau of the Guangxi Zhuang Autonomous Region has announced a significant expansion in coverage for assisted reproductive medical services under the Basic Medical Insurance (BMI) and work-related injury insurance fund. This initiative aims to enhance access to essential reproductive health services for residents in the…
